Baoqing Li, M.D.

Radiation Oncology
Baoqing Li

Comprehensive patient care has been my first priority. Each cancer patient needs evidence-based, state-of -the-art management that is individualized by a patient's choices and beliefs. In addition, biomedical science research, patient quality of life, and multi-culture background have a deep impact on me at a personal level and therefore play an equally important role in my practice of Radiation Oncology at Weill Cornell Medical College and New York Hospital Queens.

Dr. Baoqing Li is a board certified radiation oncologist and Assistant Professor of Clinical Radiation Oncology at the Weill Cornell Medical College. After earning his Ph.D. in Molecular Biology from the University of Miami School of Medicine in 2000, Dr. Li received his M.D. at New York Medical College in 2005. He completed his residency training in Radiation Oncology at the University of California, Davis Cancer Center, Sacramento, California, where he  was also Chief Resident from 2009-2010. In July 2010, Dr. Li joined the faculty of Radiation Oncology at the Weill Cornell Medical College and was appointed Assistant Professor in August 2011. Dr. Li has been full time Assistant Attending Physician at New York Hospital Queens, where he also serves as the Radiation Safety Champion. His clinical specialties are Head & Neck, Gastrointestinal, Lung, Breast, and Prostate Cancers.  He has an extensive publication in both clinical and basic science research in first-tier peer-reviewed journals. He is also actively involved in teaching and mentoring intern physicians, radiation oncology residents, and dental residents. Dr. Li received two prestigious awards from the ASCO Cancer Foundation and the American Radium Society.

A summary of Dr. Baoqing Li’s education, training, awards, and publications is listed as following:

TRAINING

Resident Physician 7/2006 to 6/2010

Departement of Radiation Oncology,

the University of California Davis Cancer Center

Sacramento, California

Intern Physician 7/2005 to 6/2006

Department of Internal Medicine

Flushing Hospital Medical Center

Flushing, New York

HONORS AND AWARDS

Name of award Date awarded

1) ASCO Cancer Foundation Merit Award 10/2010

from American Society of Clinical Oncology (ASCO)

2) Young Oncologist Award 5/2010

from American Radium Society

3) Radiation Oncology Resident Award 2/2009

from American College of Radiation Oncology

4) Ph.D. Dissertation Merit Award 5/2000

from the University of Miami

5) Travel Award 4/2005

from American Medical Association (AMA)

the 30th AMA Medical Student Research Forum

PROFESSIONAL MEMBERSHIPS

Member/officer Name of Organization Dates held

Member American Radium Society 5/1/2008

to present

Member American College 2/1/2007

of Radiation Oncology to present

(ACRO)

Member American Society 7/1/2006

of Radiation Oncology to present

(ASTRO)

Member American Association 1/1/1997

for Cancer Research to present

(AACR)

 

INVITED JOURNAL REVIEWER

Thorax

 International Journal of Radiation Oncology, Biology, and Physics

 BMC-Cancer

INVITED SPEAKER

“New Radiation Techniques in the Treatment of Rectal Cancer”. Gastrointestinal Cancers: Update 2011. Columbia University Medical Center GME course, Oct. 2011.

“SBRT for inoperable early stage lung cancer”. NYHQ Lung Cancer Symposium, Nov. 2012

“Chemotherapy and Survival in Nasopharyngeal Cancer in Asian-Americans”. 6th Annual World Cancer Congress-2013, Xi’an, China, May 2013

 

  SELECTED PUBLICATIONS (PEER-REVIEWED, ORIGINAL RESEARCH ARTICLES)

1: Stessin AM, Sison C, CK Chao, Li B.

Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database.

         Cancer 2014 Jul 15 (Epub ahead of print).

2: Stessin AM, Sison C, Nieto J, Raifu M, Li B.
The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database.
          Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):784-90.

3: Li B, Chen M, Nori D, Chao KS, Chen AM, Chen SL.
Adjuvant radiation therapy and survival for pure tubular breast carcinoma--experience from the SEER database.
          Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):23-9.

4: Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ.
Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
          Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):346-52.

5: Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White de V.
Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells.
          Prostate. 2011 May;71(6):567-74.

6: Chen AM, Hall WH, Li BQ, Guiou M, Wright C, Mathai M, Dublin A, Purdy JA.
Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
          Br J Radiol. 2011 Jan;84(997):58-63.

7: Li B, Bobinski M, Gandour-Edwards R, Farwell DG, Chen AM.
Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation.
          Br J Radiol. 2011 Jan;84(997):64-9.

8: Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA.
Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.
          Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):756-62.

9: Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Stuart K, Newman K, Purdy JA, Vijayakumar S.
Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
          Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1026-32.

10: Li B, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM, Newman K, Courquin J, Purdy JA, Chen AM.
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
          Radiat Oncol. 2009 Nov 12;4:52.

11: Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, Vijayakumar S, Purdy JA.
Late esophageal toxicity after radiation therapy for head and neck cancer.
          Head Neck. 2010 Feb;32(2):178-83.

12: Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR.
Long-term outcome of stage I seminoma.
          Am J Clin Oncol. 2007 Apr;30(2):205-10.

13: Li B, Lee MY.
Transcriptional regulation of the human DNA polymerase delta
catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
          J Biol Chem. 2001 Aug 10;276(32):29729-39.

14: Wu SM, Zhang P, Zeng XR, Zhang SJ, Mo J, Li BQ, Lee MY.
Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants. Interaction with cyclin-dependent kinase-cyclins.
          J Biol Chem. 1998 Apr 17;273(16):9561-9.

15: Sun Y, Jiang Y, Zhang P, Zhang SJ, Zhou Y, Li BQ, Toomey NL, Lee MY.
Expression and characterization of the small subunit of human DNA polymerase delta.
          J Biol Chem. 1997 May 16;272(20):13013-8.

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicaid
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Freedom]
  • POMCO
  • UHC Compass
  • United Empire
  • United Health Care [Medicare]
  • United Health Care
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

 

1: Stessin AM, Sison C, CK Chao, Li B.

 

Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database.

        

Cancer 2014 Jul 15 (Epub ahead of print).

 


2: Stessin AM, Sison C, Nieto J, Raifu M, Li B.
The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database. 
         Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):784-90.
 
3: Li B, Chen M, Nori D, Chao KS, Chen AM, Chen SL. 
Adjuvant radiation therapy and survival for pure tubular breast carcinoma--experience from the SEER database. 
         Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):23-9. 
 
4: Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ. 
Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? 
         Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):346-52. 
 
5: Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White de V.
Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. 
         Prostate. 2011 May;71(6):567-74. 
 
6: Chen AM, Hall WH, Li BQ, Guiou M, Wright C, Mathai M, Dublin A, Purdy JA.
Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer. 
         Br J Radiol. 2011 Jan;84(997):58-63. 
 
7: Li B, Bobinski M, Gandour-Edwards R, Farwell DG, Chen AM. 
Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation. 
         Br J Radiol. 2011 Jan;84(997):64-9. 
 
8: Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA. 
Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin. 
         Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):756-62. 
 
9: Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Stuart K, Newman K, Purdy JA, Vijayakumar S. 
Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. 
         Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1026-32. 
 
10: Li B, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM, Newman K, Courquin J, Purdy JA, Chen AM. 
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
         Radiat Oncol. 2009 Nov 12;4:52. 
 
11: Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, Vijayakumar S, Purdy JA. 
Late esophageal toxicity after radiation therapy for head and neck cancer.
         Head Neck. 2010 Feb;32(2):178-83. 

 

12: Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR. 
Long-term outcome of stage I seminoma. 
         Am J Clin Oncol. 2007 Apr;30(2):205-10.
 
13: Li B, Lee MY. 
Transcriptional regulation of the human DNA polymerase delta
catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. 
         J Biol Chem. 2001 Aug 10;276(32):29729-39. 
 
14: Wu SM, Zhang P, Zeng XR, Zhang SJ, Mo J, Li BQ, Lee MY. 
Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants. Interaction with cyclin-dependent kinase-cyclins. 
         J Biol Chem. 1998 Apr 17;273(16):9561-9. 
 
15: Sun Y, Jiang Y, Zhang P, Zhang SJ, Zhou Y, Li BQ, Toomey NL, Lee MY.
Expression and characterization of the small subunit of human DNA polymerase delta. 

       J Biol Chem. 1997 May 16;272(20):13013-8. 

 

Honors and Awards

Name of award Date awarded

1) ASCO Cancer Foundation Merit Award 10/2010

from American Society of Clinical Oncology (ASCO)

2) Young Oncologist Award 5/2010

from American Radium Society

3) Radiation Oncology Resident Award 2/2009

from American College of Radiation Oncology

4) Ph.D. Dissertation Merit Award 5/2000

from the University of Miami

5) Travel Award 4/2005

from American Medical Association (AMA)

the 30th AMA Medical Student Research Forum